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Abstract
Introduction: A patient with D-TGA and surgical repair (Mustard's procedure) presented with 
appropriate   ICD   shocks   due   to   monomorphic   ventricular   tachycardia,   refractory   to 
antiarrhythmic   medications                                                                        
Methods and Results:  The patient underwent an electrophysiological study and catheter 
ablation   for   the   VT.   Substrate   and   pace   mapping   techniques,   with   the   help   of   an 
electroanatomical mapping system, was used to localize and ablate the tachycardia successfully. 
Conclusions: In patients with D-TGA and Mustard's repair, scar tissue resulting from VSD 
repair can act as a substrate for recurrent VT. Catheter ablation of VT is useful in management 
of VT that occurs despite antiarrhythmic therapy and/or when it is unstable.                         
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Background
Dextro- transposition of the great arteries (D-TGA) with palliative intra-atrial redirection 
surgery (Mustard or Senning procedures) has one of the highest sudden cardiac death (SCD) 
risks in patients with congenital heart disease. In patients with D-TGA high rates of appropriate 
Implantable Cardioverter- Defibrillator (ICD) shocks for ventricular tachycarrhythmias have 
been noted [1,2,3]. We report the case of a patient with D-TGA, and an ICD presenting with 
drug refractory ventricular tachycardia and frequent ICD shocks, who underwent catheter 
ablation.
Methods and Results                                                                                               
Our patient is a 35 years old man, with D-TGA, ventricular septal defect (VSD), and mild sub-
pulmonic stenosis (PS)  at  birth. He  underwent  atrial  septostomy with  pulmonary artery (PA) 
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banding (Blalock-Hanlon) three months after birth. Following this he underwent intra-atrial 
baffle   rerouting   (Mustard's   repair)   with   closure   of   the   VSD   at   three   years   of   age.
In 2003 he survived a cardiac arrest secondary to ventricular fibrillation (VF) and was left with 
residual anoxic brain injury resulting in severe short-term memory impairment. He received a 
single chamber transvenous ICD following this event. During the ensuing years he had four 
appropriate ICD therapies for monomorphic VT varying in cycle length (CL) between 320 and 
350 ms. The patient was started on beta-blockers and Amiodarone (300 mg maintenance dose) 
for prevention of VT. He continued to have ICD shocks for monomorphic VT while on 
antiarrhythmic therapy. After discussion with the patient and his family, an electrophysiological 
(EP) study and catheter ablation for VT was performed. Cardiac imaging prior to the procedure 
showed systemic ventricular dysfunction with a calculated ejection fraction ranging from 35-
40% along with mild venous ventricular systolic dysfunction. The intra-atrial baffles were 
patent   and   the   atrioventricular   and   ventriculo-arterial   valves   were   normal.
The EP study was performed under intravenous general anesthesia. Vascular access was 
obtained from the groin (three right femoral venous sheaths and one arterial sheath) using the 
Seldinger technique. ICD therapies were turned off and the ICD was programmed to the VOO 
pacing mode at a rate of 80 bpm. The EP study was performed while the patient was on 300 mg 
of Amiodarone and 5 mg of Bisoprolol a day.                                                               
A sustained monomorphic VT with a CL of 350 ms was induced during programmed electrical 
stimulation (figure 1). The patient was not able to tolerate the VT hemodynamically for more 
than 40 seconds. The tachycardia was terminated using an external, biphasic DC shock of 300 
Joules. The 12 lead EKG during the VT showed an rS pattern in V1 with precordial transition in 
lead V3 and positive qRs complexes in leads II, III and aVF. Q waves were present in leads I, 
aVL and aVR. Based on these EKG findings we provisionally localized the VT to the septal 
region of the outflow tract of the systemic ventricle (anatomic RV in the sub aortic position).
Figure 1: This figure shows 12 lead EKGs obtained during the EP study. Image 1 (top) shows the sustained 
monomorphic VT induced at the beginning of the study. Image 2 (bottom) shows the EKG with the best pace 
match   obtained   during   pacemapping.                                                                      
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A   substrate   map   of   the   systemic   ventricle   was   created   using   a   non-fluoroscopic 
electroanatomical mapping system (CARTO, Biosense Webster Inc.) during ventricular pacing 
at a rate of 80 bpm (the patient had advanced AV conduction system disease and was pacing 
dependent). A Navistar thermocool catheter (3.5mm-tip saline-irrigated catheter; Biosense-
Webster, Inc., Diamond Bar, CA) was used for electroanatomical mapping. Intravenous 
unfractionated heparin was used to keep the activated clotting time (ACT) > 240 seconds for the 
duration   of   the   procedure.                                                                            
Bipolar contact electrograms were recorded and used to create a three-dimensional map of the 
chamber, based on voltage amplitude. After creating an electroanatomical map of the ascending 
Aorta and the systemic ventricle we performed image integration (figure2). Areas with voltages 
greater than 1.5 mV were considered 'healthy' and those with voltages less than 0.5 mV were 
considered 'scarred'. Areas with voltages between 1.5 and 0.5 mV were considered 'unhealthy'. 
A discrete scarred region in the ventricular septal region of the systemic ventricle, just below 
the Aorta, was observed. This area correlated with the site of VSD patch repair. The scar 
occupied one third of the basal interventricular septum (figure 2).
Figure 2: This image shows electroanatomical maps of the systemic ventricle and the ascending aorta integrated 
with the contrast enhanced CT image of the patient's heart. The image shows ablation lesions and the scarred 
interventricular   septum   of   the   heart.                                                                            
We then performed pace mapping at a CL of 450 ms at different sites in the systemic ventricle 
till we obtained a 12/12 match with the induced tachycardia. The site of 12/12-pace match was 
at the edge of the scar in the interventricular septum, in the systemic ventricle just below the 
Aortic coronary cusp (figure 3). Local bipolar electrograms at this site and all along the scar 
edge showed fragmented low voltage electrograms (Figure 4). Linear radiofrequency ablation 
lesions (power of 40 W for a maximum duration of 180 s at a time) were delivered from the exit 
site toward the center of the substrate and along the scar border zone perpendicular to the first 
line. Each line was composed of multiple sequential lesions placed ~5 mm apart. All lesions 
were made at the 1.0 - 1.5 mV border.  Ablations were continued until the local electrogram was 
reduced to < 25% (of the amplitude at the start of the ablation), converted to a qs complex or 
split [4,5].
After RF ablation, attempts to reinduce VT, including programmed electrical and burst pacing 
from the systemic and venous ventricle were undertaken. No ventricular arrhythmias were 
induced. We deemed this a satisfactory endpoint, as the VT was easily inducible prior to 
catheter ablation. The patient withstood the procedure without any acute complications. The 
patient  is  being  followed  up  in  the  ICD  clinic  and  has  not  had  any  further  ventricular 
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arrhythmias during the past ten months. Amiodarone has been discontinued and the patient 
continues to be on Bisoprolol.
Figure 3: This image shows electroanatomical maps of the systemic ventricle and the ascending aorta integrated 
with the contrast enhanced CT image of the patient's heart. The image shows sites used for pacemapping during the 
EP   study.                                                                      
Figure 4: This image shows local bipolar electrograms from the ablation catheter. The indicates signals from the 
distal ablation catheter. Fragmented, low voltage signals (0.5-1.5mV) were recorded from the edge of the scar in 
the interventricular septum in the outflow tract of the systemic ventricle below the aortic valve. Ablations were 
delivered in this region rendering the VT non-inducible.                                                                   
Discussion
Our patient was selected for catheter ablation of VT as he was having multiple appropriate ICD 
shocks while on  maximally  tolerated  antiarrhythmic  medications. The  patient  had  a  single- 
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inducible; scar related, monomorphic VT that was not hemodynamically tolerated. The CL of 
the VT was identical to VTs recorded by the patient's  ICD.   Activation mapping and 
entrainment maneuvers could not be performed because of hemodynamic instability. Therefore, 
substrate and pacemapping to localize the origin of the VT were performed.                         
Unlike entrainment mapping, which is performed while the patient is in VT, one cannot be 
certain about whether a particular site is within a critical portion of a VT circuit. The best 
pacemap site provides a general idea of where the VT exits allowing the operator to deliver 
targeted lesions around critical areas of the VT circuit. This is a probabilistic approach to VT 
ablation with limitations, but it has the advantage of being performed in sinus rhythm - thereby 
allowing the operator to target even hemodynamically unstable VTs [4,5]. We had an acceptable 
acute endpoint of non-inducibility of VT after the catheter ablation. However, the patient was 
loaded on Amiodarone and it is possible that VT could have been induced had the patient not 
been   on   antiarrhythmic   medication.                                                                    
Zeppenfeld and colleagues have presented insights from VT ablation in patients with tetralogy 
of Fallot (TOF) and intracardiac repair. They identified isthmuses around the region of patch 
annuloplasty and ventricular septal defect repair in the venous ventricle thought to be 
responsible for genesis of ventricular arrhythmias. Catheter ablation transecting anatomical 
isthmuses around scars along with entrainment pace mapping and substrate ablation was 
successful in preventing arrhythmia recurrence in these patients. In our case the clinical VT 
originated in the systemic ventricle and was not hemodynamically well tolerated. This 
prevented us from performing entrainment mapping and delineating the arrhythmia circuit. 
Therefore, we resorted to pace mapping to localize the exit site of the VT and used voltage 
based substrate ablation in and around the scar. We were not able to identify a clear anatomical 
isthmus at this site (with the Aortic or mitral annulus) and therefore did not perform transecting 
linear isthmus ablation as described by Zeppenfeld [4].                                                                 
Advances in imaging and mapping technologies have made ablation of arrhythmias in patients 
with congenital heart disease safe and effective. However, difficulties in obtaining vascular 
access  to cardiac  chambers  and the potential  for major complications  such as  cardiac 
perforation, intra-atrial baffle tears and damage to cardiac valves should be kept in mind while 
selecting patients for catheter ablation.                                                                       
Conclusions
In patients with D-TGA and Mustard's repair scar tissue resulting from VSD repair can act as a 
substrate for recurrent VT. Catheter ablation of VT is useful in management of VT that occurs 
despite antiarrhythmic therapy and/or when it is unstable.                                              
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